Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1993 | 1 |
2003 | 1 |
2012 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency due to a late component of complement deficiency"
Page 1
Deficiencies and excessive human complement system activation in disorders of multifarious etiology.
Adv Clin Exp Med. 2012 Jan-Feb;21(1):105-14.
Adv Clin Exp Med. 2012.
PMID: 23214307
Free article.
Review.
C3 protein plays a major role in the complement activation and generation of immune responses. Deficiencies of the C3 and other complement components, so-called early and late complement proteins, contribute to the emergence of recurrent bacteri …
C3 protein plays a major role in the complement activation and generation of immune responses. Deficiencies of the C3 and other co …
Multi-component meningococcal serogroup B (MenB)-4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency.
van den Broek B, van Els CACM, Kuipers B, van Aerde K, Henriet SS, de Groot R, de Jonge MI, Langereis JD, van der Flier M.
van den Broek B, et al.
Clin Exp Immunol. 2019 Dec;198(3):381-389. doi: 10.1111/cei.13368. Epub 2019 Oct 1.
Clin Exp Immunol. 2019.
PMID: 31487400
Free PMC article.
Vaccination against meningococcal serogroup B is recommended for patients with a complement deficiency; however, although immunogenicity in this patient group has been shown, efficacy has not yet been established. In this study, we collected serum from children with …
Vaccination against meningococcal serogroup B is recommended for patients with a complement deficiency; however, although immu …
Item in Clipboard
Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients.
Platonov AE, Vershinina IV, Käyhty H, Fijen CA, Würzner R, Kuijper EJ.
Platonov AE, et al.
Int Arch Allergy Immunol. 2003 Apr;130(4):314-21. doi: 10.1159/000070219.
Int Arch Allergy Immunol. 2003.
PMID: 12740533
BACKGROUND: Thirty-one Russian patients with late complement component deficiency (LCCD) who had experienced one to five meningococcal infections were immunized with meningococcal polysaccharide vaccine (A + C + W135 + Y) and were followed for 3-8 year …
BACKGROUND: Thirty-one Russian patients with late complement component deficiency (LCCD) who had experienced one …
Item in Clipboard
Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals.
Andreoni J, Käyhty H, Densen P.
Andreoni J, et al.
J Infect Dis. 1993 Jul;168(1):227-31. doi: 10.1093/infdis/168.1.227.
J Infect Dis. 1993.
PMID: 8515116
This study sought to quantitate the response of late complement component-deficient (LCCD) individuals to the meningococcal vaccine, to examine antibody persistence, and to investigate the contribution of these antibodies to meningococcal killing in comple …
This study sought to quantitate the response of late complement component-deficient (LCCD) individuals to the meningoco …
Item in Clipboard
Cite
Cite